Nef performance in macrophages: The master orchestrator of viral persistence and spread

Current HIV Research

Volumn 9, Issue 7, 2011, Pages 505-513

  Ghiglione, Yanina ^a   Turk, Gabriela ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

HIV; Immune escape; Immunopathogenesis; Macrophages; Nef; Viral persistence; Viral reservoir

Indexed keywords

CD23 ANTIGEN; CD4 ANTIGEN; CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOPHAGY; CELL FUNCTION; CHOLESTEROL TRANSPORT; CYTOKINE RELEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTRACELLULAR SIGNALING; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PHAGOCYTOSIS; PROTEIN FUNCTION; REVIEW; VIRION; VIRUS TRANSMISSION;

HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MACROPHAGES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84856501624     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211798842080     Document Type: Review

References (125)

1. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 Infection. N Engl J Med 2011 May 19; 364(20): 1943-54.
2. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009; 60: 471-84.
3. Hazenberg MD, Stuart JW, Otto SA, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95(1): 249-55.
4. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5(1): 83-9.
5. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997: 187-228.
6. Paiardini M, Pandrea I, Apetrei C, Silvestri G. Lessons learned from the natural hosts of HIV-related viruses. Annu Rev Med 2009; 60: 485-95.
7. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12(12): 1365-71.
8. Estes JD, Harris LD, Klatt NR, et al. Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections. PLoS Pathog 2010; 6(8): e1001052.
9. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. The J Infect Dis 2009; 199(8): 1177-85.
10. Marchetti G, Bellistri GM, Borghi E, et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008; 22(15): 2035-8.
11. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008; 8(6): 447-57.
12. Shen R, Meng G, Ochsenbauer C, et al. Stromal Down-Regulation of Macrophage CD4/CCR5 Expression and NF-kappaB Activation Mediates HIV-1 Non-Permissiveness in Intestinal Macrophages. PLoS Pathog 2011; 7(5): e1002060.
13. Ellery PJ, Tippett E, Chiu YL, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 2007; 178(10): 6581-9.
14. Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, Delfraissy JF. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 23(2): 114-9.
15. Zhu T, Muthui D, Holte S, et al. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002; 76(2): 707-16.
16. Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009; 6: 118.
17. Ho DD, Zhang L. HIV-1 rebound after anti-retroviral therapy. Nature medicine 2000; 6(7): 736-7.
18. Waki K, Freed EO. Macrophages and Cell-Cell Spread of HIV-1. Viruses 2010; 2(8): 1603-20.
19. Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M. HIV-1 assembly in macrophages. Retrovirology 2010; 7: 29.
20. Bergamaschi A, Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010; 7: 31.
21. Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010; 7: 30.
22. Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology. 2010; 7: 34.
23. Herbein G, Varin A. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 2010; 7: 33.
24. Le Douce V, Herbein G, Rohr O, Schwartz C. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 2010; 7: 32.
25. Coleman CM, Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009; 6: 51.
26. Collini P, Noursadeghi M, Sabroe I, Miller RF, Dockrell DH. Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity. Curr Mol Med 2010; 10(8): 727-40.
27. Kuroda MJ. Macrophages: do they impact AIDS progression more than CD4 T cells? J Leukoc Biol 2010; 87(4): 569-73.
28. Ayinde D, Maudet C, Transy C, Margottin-Goguet F. Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr? Retrovirology 2010; 7: 35.
29. Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991; 350(6318): 508-11.
30. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D. Nefinduced CD4 and major histocompatibility complex class I (MHCI) down-regulation are governed by distinct determinants: Nterminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 1999; 73(3):1964-73.
31. Mariani R, Skowronski J. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci USA 1993; 90(12): 5549-53.
32. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996; 2(3): 338-42.
33. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 1998; 8(22): 1235-8.
34. Foti M, Mangasarian A, Piguet V, Lew DP, Krause KH, Trono D, et al. Nef-mediated clathrin-coated pit formation. J Cell Biol 1997; 139(1): 37-47.
35. Greenberg M, DeTulleo L, Rapoport I, Skowronski J, Kirchhausen T. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr Biol 1998; 8(22): 1239-42.
36. Greenberg ME, Bronson S, Lock M, Neumann M, Pavlakis GN, Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 downregulation. Embo J 1997; 16(23): 6964-76.
37. Lindwasser OW, Smith WJ, Chaudhuri R, Yang P, Hurley JH, Bonifacino JS. A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J Virol 2008; 82(3): 1166-74.
38. Chaudhuri R, Mattera R, Lindwasser OW, Robinson MS, Bonifacino JS. A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex. J Virol 2009; 83(6): 2518-30.
39. Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, Littman DR. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990; 60(5): 755-65.
40. Laguette N, Bregnard C, Bouchet J, Benmerah A, Benichou S, Basmaciogullari S. Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. J Virol 2009; 83(14): 7117-28.
41. Vigerust DJ, Egan BS, Shepherd VL. HIV-1 Nef mediates posttranslational down-regulation and redistribution of the mannose receptor. J Leukoc Biol 2005; 77(4): 522-34.
42. Mwimanzi P, Hasan Z, Hassan R, Suzu S, Takiguchi M, Ueno T. Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages. Retrovirology 2011; 8(1): 50.
43. Hiyoshi M, Suzu S, Yoshidomi Y, Hassan R, Harada H, Sakashita N, et al. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Blood 2008; 111(1): 243-50.
44. Lama J. The physiological relevance of CD4 receptor downmodulation during HIV infection. Curr HIV Res 2003; 1(2): 167-84.
45. Levesque K, Finzi A, Binette J, Cohen EA. Role of CD4 receptor down-regulation during HIV-1 infection. Curr HIV Res 2004; 2(1): 51-9.
46. Arganaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J. Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J Biol Chem 2003; 278(36): 33912-9.
47. Brown A, Moghaddam S, Kawano T, Cheng-Mayer C. Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages. J Gen Virol 2004; 85(Pt 6): 1463-9.
48. Noviello CM, Benichou S, Guatelli JC. Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J Virol 2008; 82(3): 1249-58.
49. Singh RK, Lau D, Noviello CM, Ghosh P, Guatelli JC. An MHC-I cytoplasmic domain/HIV-1 Nef fusion protein binds directly to the mu subunit of the AP-1 endosomal coat complex. PLoS One 2009; 4(12): e8364.
50. Schaefer MR, Wonderlich ER, Roeth JF, Leonard JA, Collins KL. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog 2008; 4(8): e1000131.
51. Wonderlich ER, Williams M, Collins KL. The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J Biol Chem 2008; 283(6): 3011-22.
52. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998; 391(6665): 397-401.
53. Schindler M, Munch J, Kutsch O, et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006; 125(6): 1055-67.
54. Schindler M, Schmokel J, Specht A, et al. Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection. PLoS Pathog 2008; 4(7): e1000107.
55. Brown A, Gartner S, Kawano T, Benoit N, Cheng-Mayer C. HLAA2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus. J Leukoc Biol 2005; 78(3): 675-85.
56. Schindler M, Wildum S, Casartelli N, Doria M, Kirchhoff F. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors. AIDS 2007; 21(9): 1103-7.
57. Stumptner-Cuvelette P, Morchoisne S, Dugast M, et al. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A 2001; 98(21): 12144-9.
58. Turk G, Gundlach S, Carobene M, Schindler M, Salomon H, Benaroch P. Single Nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions. AIDS Res Hum Retroviruses 2009; 25(3): 285-96.
59. Schmokel J, Li H, Bailes E, Schindler M, Silvestri G, Hahn BH, et al. Conservation of Nef function across highly diverse lineages of SIVsmm. Retrovirology 2009; 6: 36.
60. Toussaint H, Gobert FX, Schindler M, et al. Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain. J Virol 2008; 82(17): 8373-82.
61. Chaudhry A, Verghese DA, Das SR, Jameel S, George A, Bal V, et al. HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol 2009; 183(4): 2415-24.
62. Stumptner-Cuvelette P, Jouve M, Helft J, et al. Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol Biol Cell 2003; 14(12): 4857-70.
63. Mitchell RS, Chaudhuri R, Lindwasser OW, et al. Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 Nef. J Virol 2008; 82(16): 7758-67.
64. Schindler M, Wurfl S, Benaroch P, et al. Down-Modulation of Mature Histocompatibility Complex Class II and Up-Regulation of Invariant Chain Cell Surface Expression are Well-Conserved Functions of Human and Simian Immunodeficiency Virus nef Alleles. J Virol 2003; 77(19): 10548-56.
65. Munch J, Schindler M, Wildum S, et al. Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication. J Virol 2005; 79(16): 10547-60.
66. Schindler M, Munch J, Brenner M, Stahl-Hennig C, Skowronski J, Kirchhoff F. Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques. J Virol 2004; 78(19): 10588-97.
67. Kirchhoff F, Schindler M, Bailer N, et al. Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors. J Virol 2004; 78(13): 6864-74.
68. Ghiglione Y, Rodriguez AM, De Candia CA, et al. HIV-mediated Up-regulation of Invariant Chain (CD74) Correlates with Generalized Immune Activation in HIV+ Subjects. Virus Research 2011; In Press.
69. Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cellsurface CCR5 and CD4. Curr Biol 2005; 15(8): 714-23.
70. Chaudhry A, Das SR, Hussain A, et al. The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 2005; 175(7): 4566-74.
71. Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, Xu XN. HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A 2005; 102(31): 11017-22.
72. Olivetta E, Percario Z, Fiorucci G, et al. HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol 2003; 170(4): 1716-27.
73. Percario Z, Olivetta E, Fiorucci G, et al. Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery. J Leukoc Biol 2003; 74(5): 821-32.
74. Federico M, Percario Z, Olivetta E, et al. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 2001; 98(9): 2752-61.
75. Briggs SD, Scholtz B, Jacque JM, Swingler S, Stevenson M, Smithgall TE. HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J Biol Chem 2001; 276(27): 25605-11.
76. Swingler S, Brichacek B, Jacque JM, Ulich C, Zhou J, Stevenson M. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 2003; 424(6945): 213-9.
77. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 2001; 410(6830): 834-8.
78. Muthumani K, Choo AY, Hwang DS, et al. HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation. Blood 2005; 106(6): 2059-68.
79. Alessandrini L, Santarcangelo AC, Olivetta E, et al. T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS. J Gen Virol 2000; 81(Pt 12): 2905-17.
80. James CO, Huang MB, Khan M, Garcia-Barrio M, Powell MD, Bond VC. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol 2004; 78(6): 3099-109.
81. Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams SA, Greene WC. Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J Immunol 2005; 175(9): 6050-7.
82. Alexander M, Bor YC, Ravichandran KS, Hammarskjold ML, Rekosh D. Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity. J Virol 2004; 78(4): 1685-96.
83. Wang JK, Kiyokawa E, Verdin E, Trono D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A. 2000; 97(1): 394-9.
84. Herbein G, Varin A, Larbi A, et al. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages. Curr HIV Res 2008; 6(2): 117-29.
85. Ma W, Mishra S, Gajanayaka N, Angel JB, Kumar A. HIV-1 Nef inhibits lipopolysaccharide-induced IL-12p40 expression by inhibiting JNK-activated NFkappaB in human monocytic cells. J Biol Chem 2009; 284(12): 7578-87.
86. Wolf D, Witte V, Laffert B, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 2001; 7(11): 1217-24.
87. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296(5573): 1655-7.
88. Tachado SD, Li X, Swan K, Patel N, Koziel H. Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro. J Biol Chem 2008; 283(48): 33191-8.
89. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998; 95(2): 163-75.
90. Hanna Z, Weng X, Kay DG, Poudrier J, Lowell C, Jolicoeur P. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 2001; 75(19): 9378-92.
91. Verollet C, Zhang YM, Le Cabec V, et al. HIV-1 Nef triggers macrophage fusion in a p61Hck-and protease-dependent manner. J Immunol 2010; 184(12): 7030-9.
92. Dargent JL, Lespagnard L, Kornreich A, Hermans P, Clumeck N, Verhest A. HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: a detailed study. Mod Pathol 2000; 13(12): 1293-9.
93. Lewin-Smith M, Wahl SM, Orenstein JM. Human immunodeficiency virus-rich multinucleated giant cells in the colon: a case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization. Mod Pathol 1999; 12(1):75-81.
94. Nardacci R, Antinori A, Kroemer G, Piacentini M. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia. Cell Death Differ 2005; 12 Suppl 1: 855-8.
95. Hiyoshi M, Takahashi-Makise N, Yoshidomi Y, et al. HIV-1 Nef perturbs the function, structure, and signaling of the golgi through the Src kinase Hck. J Cell Physiol May 12.
96. Quaranta MG, Mattioli B, Giordani L, Viora M. Immunoregulatory effects of HIV-1 Nef protein. Biofactors. 2009 Mar-Apr; 35(2): 169-74.
97. Swingler S, Mann A, Jacque J, et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 1999; 5(9): 997-103.
98. Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR. Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier. Brain Res 2011; 1399: 96-115.
99. Quaranta MG, Camponeschi B, Straface E, Malorni W, Viora M. Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells. Exp Cell Res 1999; 250(1): 112-21.
100. Dai L, Stevenson M. A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol 2010; 84(16): 8327-31.
101. Swingler S, Zhou J, Swingler C, et al. Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 2008; 4(1):63-76.
102. Xu W, Santini PA, Sullivan JS, et al. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009; 10(9): 1008-17.
103. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007; 81(2): 1000-12.
104. Carr JM, Hocking H, Li P, Burrell CJ. Rapid and efficient cell-tocell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 1999; 265(2): 319-29.
105. Sharova N, Swingler C, Sharkey M, Stevenson M. Macrophages archive HIV-1 virions for dissemination in trans. Embo J 2005; 24(13): 2481-9.
106. Muratori C, Sistigu A, Ruggiero E, et al. Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9. J Virol 2007; 81(17): 9078-87.
107. Gousset K, Ablan SD, Coren LV, et al. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog 2008; 4(3): e1000015.
108. Groot F, Welsch S, Sattentau QJ. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 2008; 111(9): 4660-3.
109. Bennett AE, Narayan K, Shi D, et al. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog 2009; 5(9): e1000591.
110. Eugenin EA, Gaskill PJ, Berman JW. Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. Cell Immunol 2009; 254(2): 142-8.
111. Kadiu I, Gendelman HE. Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and golgi network. J Proteome Res 2011; 10(7): 3225-38.
112. Nobile C, Rudnicka D, Hasan M, et al. HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. J Virol 2010; 84(5): 2282-93.
113. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9(4): 235-45.
114. Mazzolini J, Herit F, Bouchet J, Benmerah A, Benichou S, Niedergang F. Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood 2010; 115(21): 4226-36.
115. Sir D, Ou JH. Autophagy in viral replication and pathogenesis. Mol Cells 2010; 29(1): 1-7.
116. Campbell GR, Spector SA. Hormonally active vitamin D3 (1alpha, 25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011; 286(21): 18890-902.
117. Espert L, Varbanov M, Robert-Hebmann V, et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009; 4(6): e5787.
118. Kyei GB, Dinkins C, Davis AS, et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 2009; 186(2): 255-68.
119. Li JC, Au KY, Fang JW, et al. HIV-1 trans-activator protein dysregulates IFN-gamma signaling and contributes to the suppression of autophagy induction. AIDS 2011; 25(1): 15-25.
120. Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS. HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 2010; 5(7): e11733.
121. Olivetta E, Federico M. HIV-1 Nef protects human-monocytederived macrophages from HIV-1-induced apoptosis. Exp Cell Res. 2006; 312(6): 890-900.
122. Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M. The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol 2010; 87(4): 589-98.
123. Asztalos BF, Mujawar Z, Morrow MP, et al. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis 2010; 202(4): 614-23.
124. Mujawar Z, Rose H, Morrow MP, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol 2006; 4(11): e365.
125. Mujawar Z, Tamehiro N, Grant A, Sviridov D, Bukrinsky M, Fitzgerald ML. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry 2010; 49(38): 8338-49.